Ibex® Design – Gene to IND in the fast lane
Ibex® Design is our fixed scope, fastest gene-to-IND offering, delivering GMP drug product for your clinical phase 1 trials within 14 months, with an option to supply tox drug product in only 9 months. To further increase predictability, we commit to a minimum quantity of 1.5 kg GMP drug substance material for your phase 1 clinical needs and we keep a manufacturing slot reserved for your clinical resupply. Benefit from our proven GS Gene Expression System® and over 30 years of track record in cell line development to accelerate your path to the clinic without increased risk
*For antibodies and antibody like molecules. From receipt of the gene sequence. Subject to terms and conditions.